Evidence map›Paper›PMID 35034856›Full record

ArticleJournal francais d'ophtalmologie2022

Treatment of a full-thickness macular hole and retinal detachment secondary to toxoplasma chorioretinitis that developed shortly after COVID-19: A case report.

M K Erol, Y C Bozdogan, E Suren, B Gedik

Open access · greenAbstract readCase Reports
In one paragraph

Article in Journal francais d'ophtalmologie, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

M K ErolDepartment of Ophthalmology, University of Health Sciences, Antalya Education and Research Hospital, Antalya, Turkey.
Y C BozdoganDepartment of Ophthalmology, University of Health Sciences, Antalya Education and Research Hospital, Antalya, Turkey. Electronic address: yigitcaglarbozdogan@gmail.com.
E SurenDepartment of Ophthalmology, University of Health Sciences, Antalya Education and Research Hospital, Antalya, Turkey.
B GedikSerik State Hospital, Antalya, Turkey.
Sağlık Bilimleri Üniversitesi · TRSerik Devlet Hastanesi

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although ocular toxoplasmosis is usually a self-limiting infection, it can lead to severe reduction in visual acuity due to intense vitreous inflammation or involvement of posterior segment structures. Depending on the severity of intraocular inflammation, serious complications, including epiretinal membrane or retinal detachment may develop. In this paper, we aim to present a case that complicated by both a full-thickness macular hole and retinal detachment secondary to toxoplasmosis chorioretinitis that developed shortly after the novel coronavirus disease (COVID-19) and discuss our treatment approach. After the patient was diagnosed based on a routine ophthalmological examination, fundus imaging, and serological examination, functional and anatomical recovery was achieved through systemic antibiotherapy and vitreoretinal surgery. Full-thickness macular hole and retinal detachment are rare complications of ocular toxoplasmosis. However, there are only few publications in the literature concerning these complications and their surgical treatment. In this case report, we demonstrated the success of vitreoretinal surgery combined with antibiotic therapy on the posterior segment complications of ocular toxoplasmosis.

Indexed as

ChorioretinitisCOVID-19Retinal DetachmentRetinal PerforationsToxoplasmaToxoplasmosis, OcularHumansInflammationTomography, Optical CoherenceVitrectomyCOVID-19Décollement de rétineMacular holeOcular toxoplasmosisRetinal detachmentToxoplasmaToxoplasmeToxoplasmose oculaireTrou maculaire

Identifiers

PMID35034856
PMCPMC8733215
OpenAlexW4206269963

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.